BioTime changes name to Lineage Cell Therapeutics

Company Types Academia Commercial Banking Corporations Government & Regulatory Agencies Insurance
Investment Banking Investment Management Private Equity Professional Services Industrials
Sectors Energy Finance Fintech Healthcare Metals & Mining Technology, Media & Telecom Real Estate Retail & Consumer
Capabilities Credit Analytics Credit Assessment Scorecards Investment Research Fundamental Data Leveraged Commentary & Data See All Solutions
ESG Analysis Panjiva RatingsDirect RatingsXpress 451 Research M&A Analysis
Delivery Market Intelligence Platform S&P Capital IQ Platform S&P Global China Credit Analytics Platform Data Management & Feed Solutions S&P Global Marketplace Daily Dose
Content Latest Headlines Blog Research Videos Podcasts Topics Media Center
How We Can Help COVID-19: Impact & Recovery Insights to Manage Climate Risk Credit Risk Management Tools Differentiated Data to Make Informed Decisions Client Case Studies See More
News & Insights Topics Coronavirus ESG Credit Risk M&A Supply Chain Intelligence Technology Infographics See More
All Events Webinars Webinar Replays
Featured Events
WebinarUniversity Essentials: From Crisis to Resilience – Navigating Sustainable Recovery
- 09/23/2021
- Live, Online
- 11:00 am - 12:00 pm EDT
WebinarPolitics & Policy: Global Trade, Supply Chain Disruptions & Risk
- 07/14/2021
- Live, Online
- 12:00 - 1:00 pm EDT
WebinarWhat role will enterprise technology play in advancing the ESG mandate?
- 06/29/2021
- Live, Online
- 10:00 - 10:45 am EDT
Platforms Market Intelligence Platform S&P Capital IQ Platform S&P Global China Credit Analytics Platform
Other Products Credit Analytics Leveraged Commentary and Data Money Market Directories
Research Online S&P Dow Jones Indices Panjiva

In This List

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

1 Aug, 2019

Author Annalee Armstrong
Theme Healthcare & Pharmaceuticals

BioTime Inc., a biotechnology company that focuses on developing therapies for unmet medical needs, is changing its name to Lineage Cell Therapeutics Inc.

The company's ticker will change to LCTX, effective the same day as the name change on Aug. 12, the company said July 31.

Alameda, Calif.-based BioTime said the change reflects its extensive cell therapy platform.

Request a Demo

Contact

Business

Location

Request a Demo

BioTime changes name to Lineage Cell Therapeutics